Story perspectives

Pharmaceutical Demand Fuels Multi-Billion Dollar Market Growth

9/3/2025

Summary

Story summary

The Benzhydrylamine market is projected to grow from USD 300 million in 2025 to USD 500 million by 2035, driven by pharmaceutical demand.
The porous polymers market is expected to expand from USD 9.47 billion in 2024 to USD 15.2 billion by 2032, due to drug delivery and environmental applications.
The Ethyl p-Toluenesulfonate market is set to increase from USD 4.12 billion in 2024 to USD 4.9 billion by 2032, driven by pharmaceutical and agrochemical demand.
The Cyclopropyl Acetylene market is anticipated to grow at a CAGR of 2.6% from 2025 to 2035, supported by pharmaceutical research needs.
The Aluminium Ethoxide market is evolving, influenced by a focus on nanomaterials and sustainable chemistry.

History

Historical Context

The pharmaceutical industry saw remarkable growth in 2000, with global sales reaching $400 billion, driven by companies like Pfizer and Merck. This growth reflects a broader trend towards advanced materials in pharmaceuticals, as evidenced by the projected rise of the Benzhydrylamine market from $300 million in 2025 to $500 million by 2035, emphasizing ongoing innovations in drug delivery and sustainable chemistry.

1 of 2

Story summary

The Benzhydrylamine market is projected to grow from USD 300 million in 2025 to USD 500 million by 2035, driven by pharmaceutical demand.
The porous polymers market is expected to expand from USD 9.47 billion in 2024 to USD 15.2 billion by 2032, due to drug delivery and environmental applications.
The Ethyl p-Toluenesulfonate market is set to increase from USD 4.12 billion in 2024 to USD 4.9 billion by 2032, driven by pharmaceutical and agrochemical demand.
The Cyclopropyl Acetylene market is anticipated to grow at a CAGR of 2.6% from 2025 to 2035, supported by pharmaceutical research needs.
The Aluminium Ethoxide market is evolving, influenced by a focus on nanomaterials and sustainable chemistry.

1 / 2